View in EDS

Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.

Saved in:
Bibliographic Details
Title: Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.
Authors: Boukhaled GM; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. giselle.boukhaled@uhnresearch.ca., Gadalla R; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Elsaesser HJ; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Abd-Rabbo D; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Quevedo R; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Yang SYC; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Guo M; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada., Wang BX; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Noamani B; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Gray D; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Lau SCM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Medical Oncology, Perlmutter Cancer Center, NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA., Taylor K; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada., Aung K; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada., Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada., Saibil SD; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Hirano N; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada., Guidos C; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.; Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada., Pugh TJ; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., McGaha TL; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada., Ohashi PS; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada., Sacher AG; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada., Butler MO; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Brooks DG; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. dbrooks@uhnresearch.ca.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada. dbrooks@uhnresearch.ca.
Source: Nature immunology [Nat Immunol] 2022 Aug; Vol. 23 (8), pp. 1273-1283. Date of Electronic Publication: 2022 Jul 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35835962
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boukhaled+GM%22">Boukhaled GM</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. giselle.boukhaled@uhnresearch.ca.<br /><searchLink fieldCode="AU" term="%22Gadalla+R%22">Gadalla R</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Elsaesser+HJ%22">Elsaesser HJ</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Abd-Rabbo+D%22">Abd-Rabbo D</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Quevedo+R%22">Quevedo R</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yang+SYC%22">Yang SYC</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Guo+M%22">Guo M</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Wang+BX%22">Wang BX</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Noamani+B%22">Noamani B</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Gray+D%22">Gray D</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Lau+SCM%22">Lau SCM</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Medical Oncology, Perlmutter Cancer Center, NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Taylor+K%22">Taylor K</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Aung+K%22">Aung K</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Spreafico+A%22">Spreafico A</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hansen+AR%22">Hansen AR</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Saibil+SD%22">Saibil SD</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hirano+N%22">Hirano N</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Guidos+C%22">Guidos C</searchLink>; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.; Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Pugh+TJ%22">Pugh TJ</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22McGaha+TL%22">McGaha TL</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Ohashi+PS%22">Ohashi PS</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Sacher+AG%22">Sacher AG</searchLink>; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Butler+MO%22">Butler MO</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Brooks+DG%22">Brooks DG</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. dbrooks@uhnresearch.ca.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada. dbrooks@uhnresearch.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100941354%22">Nature immunology</searchLink> [Nat Immunol] 2022 Aug; Vol. 23 (8), pp. 1273-1283. <i>Date of Electronic Publication: </i>2022 Jul 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Inc%22">Nature America Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100941354 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-2916 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215292908%22">15292908 </searchLink><i>NLM ISO Abbreviation: </i>Nat Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35835962
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41590-022-01262-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1273
    Titles:
      – TitleFull: Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boukhaled GM
      – PersonEntity:
          Name:
            NameFull: Gadalla R
      – PersonEntity:
          Name:
            NameFull: Elsaesser HJ
      – PersonEntity:
          Name:
            NameFull: Abd-Rabbo D
      – PersonEntity:
          Name:
            NameFull: Quevedo R
      – PersonEntity:
          Name:
            NameFull: Yang SYC
      – PersonEntity:
          Name:
            NameFull: Guo M
      – PersonEntity:
          Name:
            NameFull: Wang BX
      – PersonEntity:
          Name:
            NameFull: Noamani B
      – PersonEntity:
          Name:
            NameFull: Gray D
      – PersonEntity:
          Name:
            NameFull: Lau SCM
      – PersonEntity:
          Name:
            NameFull: Taylor K
      – PersonEntity:
          Name:
            NameFull: Aung K
      – PersonEntity:
          Name:
            NameFull: Spreafico A
      – PersonEntity:
          Name:
            NameFull: Hansen AR
      – PersonEntity:
          Name:
            NameFull: Saibil SD
      – PersonEntity:
          Name:
            NameFull: Hirano N
      – PersonEntity:
          Name:
            NameFull: Guidos C
      – PersonEntity:
          Name:
            NameFull: Pugh TJ
      – PersonEntity:
          Name:
            NameFull: McGaha TL
      – PersonEntity:
          Name:
            NameFull: Ohashi PS
      – PersonEntity:
          Name:
            NameFull: Sacher AG
      – PersonEntity:
          Name:
            NameFull: Butler MO
      – PersonEntity:
          Name:
            NameFull: Brooks DG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1529-2916
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Nature immunology
              Type: main
ResultId 1